Dulopair 20 Tablet is a sustained-release formulation of Duloxetine, a selective serotonin-norepinephrine reuptake inhibitor (SSNRI). It is commonly used in the treatment of depression, anxiety disorders, and certain chronic pain conditions, such as diabetic neuropathy and fibromyalgia. The sustained-release technology ensures that the medication is gradually released over time, allowing for a consistent therapeutic effect throughout the day while minimizing side effects associated with peak drug levels.
In patients with major depressive disorder (MDD), Dulopair helps to balance the levels of serotonin and norepinephrine in the brain, improving mood, energy, and overall well-being. It is also effective in treating generalized anxiety disorder (GAD), helping to reduce feelings of excessive worry, restlessness, and tension.
Dulopair 20 Tablet is beneficial for patients with chronic pain conditions, particularly diabetic peripheral neuropathy, by relieving pain and discomfort associated with nerve damage. Additionally, it is used to manage fibromyalgia, a condition characterized by widespread musculoskeletal pain, fatigue, and sleep disturbances.
The sustained-release formulation of Dulopair 20 ensures once-daily dosing, which enhances patient compliance and convenience, as it reduces the need for multiple daily doses.